JAK-IN-37
JAK-IN-37 (Compound WU4) is a JAK inhibitor, with IC50 values of 0.52, 2.26, 84 and 1.09 nM for JAK1, JAK2, JAK3 and JAK4, respectively. JAK-IN-37 can be used for the research of allogeneic hematopoietic cell transplantation (allo-HCT) [1].
Product Specifications
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jak-in-37.html
Smiles
O=S(NC(C1)CC1(C2)CC2(CC#N)N3N=CC(C4=C5C(NC=C5)=NC=N4)=C3)(CC)=O
Molecular Formula
C20H23N7O2S
Molecular Weight
425.51
References & Citations
[1]Kim S, et al. Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model. Molecules. 2024 Apr 16;29 (8) :1801.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040629-500 1x 500 µL
CD59 (heavy chain of Protectin) (MACIF/629), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472951-100 1x 100 µL
CDX2 (GI Epithelial Marker) (CDX2/2951R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 